Trademark Search  /  SYNCRETIN

SYNCRETIN

● Live · Pending

U.S. federal trademark · Serial No. 99057963

Mark
SYNCRETIN
Status
Pending
Serial Number
99057963
Filing Date
February 26, 2025
Class(es)
Class 001, Class 005, Class 040

Owners

Abiologics, Inc.
03 · Cambridge, MA, US
Abiologics, Inc.
03 · Cambridge, MA, US

Goods & Services

Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical use; custom manufacturing of synthetic proteins and peptides

Synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for use in connection with medical treatment of appetite control, body weight management, metabolism, cardiovascular and renal diseases, neurological and neurodegenerative diseases, brain health, substance use disorder, pain, neuropsychiatry, inflammation, and immunology; biomedical compounds, namely, peptide substrates used in analyzing and detecting toxins for medical purposes

Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research; synthetic proteins and synthetic peptides for use in scientific and medical research in connection with appetite control, body weight management, metabolism, cardiovascular and renal diseases, neurological and neurodegenerative diseases, brain health, substance use disorder, pain, neuropsychiatry, inflammation, and immunology; biomedical compounds, namely, peptide substrates used in analyzing and detecting toxins for research purposes

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "SYNCRETIN" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.